Answer
Yes, tebentafusp caused transient, clinically non-significant reductions in blood lymphocyte counts the day after the first three doses, with counts returning to baseline before subsequent doses.
Sources for this answer
- KIMMTRAK (tebentafusp) 200 micrograms/ mL concentrate for solution for infusionImmunocore Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated
Sources checked